TY - JOUR
T1 - Treatment of type 1 diabetes
T2 - Synopsis of the 2017 American Diabetes Association standards of medical care in diabetes
AU - Chamberlain, James J.
AU - Kalyani, Rita Rastogi
AU - Leal, Sandra
AU - Rhinehart, Andrew S.
AU - Shubrook, Jay H.
AU - Skolnik, Neil
AU - Herman, William H.
N1 - Publisher Copyright:
© 2017 American College of Physicians.
PY - 2017/10/3
Y1 - 2017/10/3
N2 - Description: The American Diabetes Association (ADA) annually updates Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and management of patients with diabetes. Methods: For the 2017 Standards of Care, the ADA Professional Practice Committee did MEDLINE searches from 1 January 2016 to November 2016 to add, clarify, or revise recommendations on the basis of new evidence. The committee rated the recommendations as A, B, or C, depending on the quality of evidence, or E for expert consensus or clinical experience. The Standards of Care were reviewed and approved by the Executive Committee of the ADA Board of Directors, which includes health care professionals, scientists, and laypersons. Feedback from the larger clinical community informed revisions. Recommendation: This synopsis focuses on recommendations from the 2017 Standards of Care about monitoring and pharmacologic approaches to glycemic management for type 1 diabetes.
AB - Description: The American Diabetes Association (ADA) annually updates Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and management of patients with diabetes. Methods: For the 2017 Standards of Care, the ADA Professional Practice Committee did MEDLINE searches from 1 January 2016 to November 2016 to add, clarify, or revise recommendations on the basis of new evidence. The committee rated the recommendations as A, B, or C, depending on the quality of evidence, or E for expert consensus or clinical experience. The Standards of Care were reviewed and approved by the Executive Committee of the ADA Board of Directors, which includes health care professionals, scientists, and laypersons. Feedback from the larger clinical community informed revisions. Recommendation: This synopsis focuses on recommendations from the 2017 Standards of Care about monitoring and pharmacologic approaches to glycemic management for type 1 diabetes.
UR - http://www.scopus.com/inward/record.url?scp=85030459270&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030459270&partnerID=8YFLogxK
U2 - 10.7326/M17-1259
DO - 10.7326/M17-1259
M3 - Article
C2 - 28892816
AN - SCOPUS:85030459270
SN - 0003-4819
VL - 167
SP - 493
EP - 498
JO - Annals of internal medicine
JF - Annals of internal medicine
IS - 7
ER -